We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study.
- Authors
West, H L; Crowley, J J; Vance, R B; Franklin, W A; Livingston, R B; Dakhil, S R; Giguere, J K; Rivkin, S E; Kraut, M; Chansky, K; Gandara, D R; Southwest Oncology Group
- Abstract
There are no published prospective trials of chemotherapy for advanced bronchioloalveolar carcinoma (BAC), a subtype of non-small-cell lung cancer for which there is no current standard therapy. This phase II study assesses the efficacy and toxicity of 96-h paclitaxel in chemotherapy-naive patients with advanced BAC.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2005, Vol 16, Issue 7, p1076
- ISSN
0923-7534
- Publication type
Journal Article
- DOI
10.1093/annonc/mdi215